Question 1

What is IMUNON?

Accepted Answer

IMUNON is a Company.

Question 2

How often does IMUNON appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was IMUNON first tracked by Ergen?

Accepted Answer

First tracked on May 06, 2025.

Question 4

When was IMUNON last mentioned in news?

Accepted Answer

Last active on Jun 26, 2026.

Question 5

What is IMUNON's current news sentiment?

Accepted Answer

Aggregate sentiment score: 45 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is IMUNON in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving IMUNON?

Accepted Answer

IMUNON IMNN-001 Ovarian Cancer Breakthrough (May 06, 2025, 6 articles).

Question 8

How did the "IMUNON IMNN-001 Ovarian Cancer Breakthrough" event impact IMUNON?

Accepted Answer

IMUNON announced positive results from its Phase 2 OVATION 2 Study for IMNN-001 in advanced ovarian cancer, showing significant improvements in overall survival and progression-free survival. This has led to the initiation of its pivotal Phase 3 OVATION 3 Study, positioning IMUNON for a potentially historic advance in ovarian cancer treatment.

Question 9

How did the "Life Sciences Virtual Investor Forum Presentations" event impact IMUNON?

Accepted Answer

IMUNON was one of the presenting companies at the Life Sciences Virtual Investor Forum.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.